News & Events

Press Releases

Microbiotica announces transition of leadership

29 November 2022/by immunocity

Microbiotica to present at key industry conferences in Q3 2022

20 June 2022/by immunocity

Microbiotica Receives Crohn’s & Colitis Foundation Funding to Develop Ulcerative Colitis Therapeutic

5 April 2022/by immunocity

Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics

7 March 2022/by immunocity

Microbiome Movement Exclusive Interview with Mike Romanos

5 May 2021/by immunocity

Microbiotica Highly Commended at Cambridge Independent Science and Technology Awards

30 April 2021/by immunocity

Microbiotica Moves Into New Building at Chesterford Research Park

19 April 2021/by immunocity

Microbiotica Appoints Hans Schikan as Independent Non-Executive Chairman

24 February 2021/by immunocity

Microbiotica Expands Management Team with Appointments of Chief Medical Officer and Chief Operating Officer

4 February 2021/by immunocity